Journal of Medicinal Chemistry p. 5284 - 5297 (2004)
Update date:2022-08-04
Topics:
Eldrup, Anne B.
Prhavc, Marija
Brooks, Jennifer
Bhat, Balkrishen
Prakash, Thazha P.
Song, Quanlai
Bera, Sanjib
Bhat, Neelima
Dande, Prasad
Cook, P. Dan
Bennett, C. Frank
Carroll, Steven S.
Ball, Richard G.
Bosserman, Michele
Burlein, Christine
Colwell, Lawrence F.
Fay, John F.
Flores, Osvaldo A.
Getty, Krista
LaFemina, Robert L.
Leone, Joseph
MacCoss, Malcolm
McMasters, Daniel R.
Tomassini, Joanne E.
Von Langen, Derek
Wolanski, Bohdan
Olsen, David B.
Hepatitis C virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified 2′-C-methyladenosine and 2′-C-methylguanosine as potent nucleoside inhibitors of HCV RNA replication in vitro. However, both of these compounds suffered from significant limitations. 2′-C-Methyladenosine was found to be susceptible to enzymatic conversions by adenosine deaminase and purine nucleoside phosphorylase, and it displayed limited oral bioavailability in the rat. 2′-C-Methylguanosine, on the other hand, was neither efficiently taken up in cells nor phosphorylated well. As part of an attempt to address these limitations, we now report upon the synthesis and evaluation of a series of heterobase-modified 2′-C-methyl ribonucleosides. The structure-activity relationship within this series of nucleosides reveals 4-amino-7-(2-C-methyl- β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine and 4-amino-5-fluoro-7-(2-C- methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine as potent and noncytotoxic inhibitors of HCV RNA replication. Both 4-amino-7-(2-C-methyl- β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine and 4-amino-5-fluoro-7-(2-C- methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine display improved enzymatic stability profiles as compared to that of 2′-C-methyladenosine. Consistent with these observations, the most potent compound, 4-amino-5-fluoro-7H-pyrrolo[2,3-d]pyrimidine ribonucleoside, is orally bioavailable in the rat. Together, the potency of the 2′-C-methyl-4-amino- pyrrolo[2,3-d]pyrimidine ribonucleosides and their improved pharmacokinetic properties relative to that of 2′-C-methyladenosine suggests that this class of compounds may have clinical utility.
View MoreShijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Zibo Xiaoguang Chemical Material Co., Ltd
Contact:15954099116
Address:Boshan Development Zone
Hubei Danao Pharmaceutical Co.,Ltd.
website:http://www.danaopharm.com
Contact:+86-719-5251167
Address:Fandan Road,Danjiangkou,Hubei
Shanghai Bosman Industrial Co., Ltd
Contact:86-21-63065878-8006
Address:Rm907, No.1611, North Sichuan Road, Hongkou District, Shanghai, 200080 China
Nanjing Yuance Industry&Trade Co., Ltd.
website:http://www.njyuance.cn/
Contact:+86-25-85439097
Address:B1702, Aoti Bldg, No. 130, Aoti Avenue, Nanjing, China
Doi:10.1081/SCC-120021043
(2003)Doi:10.1016/0040-4039(76)80104-9
(1976)Doi:10.1021/jm030230z
(2003)Doi:10.1016/S0022-328X(00)94080-4
(1979)Doi:10.1016/S0957-4166(97)00284-X
(1997)Doi:10.1016/j.tetlet.2003.08.029
(2003)